{"id":9393,"date":"2018-01-27T05:00:36","date_gmt":"2018-01-27T10:00:36","guid":{"rendered":"https:\/\/medicarereport.org\/?p=9393"},"modified":"2018-01-26T10:22:49","modified_gmt":"2018-01-26T15:22:49","slug":"states-taking-different-approaches-to-telemedicine-to-help-doctors-prescribe-controlled-substances","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=9393","title":{"rendered":"States taking different approaches to telemedicine to help doctors prescribe controlled substances"},"content":{"rendered":"<p>Doctors and pharmacists see telemedicine and telehealth as an opportunity to improve outcomes by improving the distribution and management of controlled substances; however, the U.S. Drug Enforcement Agency\u2019s Ryan Haight Act sets very strict limits on how those digital health platforms and tools are used. State legislatures and medical boards are tackling the issue. <a href=\"https:\/\/mhealthintelligence.com\/news\/how-are-states-using-telemedicine-to-tackle-the-opioid-abuse-crisis?elqTrackId=13b0b495d43a4ff3bf9a471a2aa58a3c&amp;elq=1a9ab8dc6d6e49a79789c0994c66de25&amp;elqaid=4551&amp;elqat=1&amp;elqCampaignId=4212\">Read article here\u2026<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/stethascope-.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-7791\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/stethascope--300x240.jpg\" alt=\"\" width=\"300\" height=\"240\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/stethascope--300x240.jpg 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/stethascope-.jpg 700w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>Doctors and pharmacists see telemedicine and telehealth as an opportunity to improve outcomes by improving the distribution and management of<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10,33],"tags":[],"class_list":["post-9393","post","type-post","status-publish","format-standard","hentry","category-legislative-update","category-telehealth"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/9393","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9393"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/9393\/revisions"}],"predecessor-version":[{"id":9394,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/9393\/revisions\/9394"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9393"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9393"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9393"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}